サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439640

神経血管塞栓デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
神経血管塞栓デバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経血管塞栓デバイスの市場規模は、2023年に12億9,000万米ドル、2030年までに15億9,000万米ドルに達し、2024年～2030年の予測期間にCAGRで3.50％の成長が見込まれます。神経血管塞栓デバイスの需要の増加は主に、脳内出血や血管異常の有病率の増加、座りがちなライフスタイルによる脳動脈瘤や動静脈奇形（AVM）の増加に起因しています。さらに、老年人口の増加、高血圧の有病率の増加、さまざまな塞栓製品の発売などが、世界の神経血管塞栓デバイス市場の成長要因となっています。

神経血管塞栓デバイスの市場力学

神経血管塞栓デバイス市場は、人々の出血や脳動脈瘤の有病率が上昇していることから、現在勢いを増しています。公的医療制度であるNational Health Service（NHS）によると、喫煙、重度の頭部外傷、コカインの乱用、血圧の上昇など、脳動脈瘤の発症リスクを高める要因は数多くあり、神経血管塞栓デバイスの需要の増加につながる可能性があります。例えば、世界保健機関（WHO）が2023年に発表したデータによると、30～79歳の成人約12億8,000万人が世界中で高血圧症に罹患しています。また、高血圧患者の3分の2は低中所得国に住んでいるというデータもあります。

さらに、老年人口の拡大が続いていることも、今後数年間の神経血管塞栓デバイス市場に寄与する可能性があります。脳動脈瘤は30～60歳の成人に多く、男性よりも女性に多いからです。国連経済社会局人口部（UN DESA）が発表したWorld Population Ageing 2020 Highlightsによると、2020年に全世界で65歳以上の高齢者が7億2,700万人になると推定されています。同レポートによると、女性は高齢者の大部分を占め、特に高齢者では、2020年の65歳以上の世界人口の55％を占めています。

加えて、塞栓製品の承認も市場成長に寄与すると可能性があります。例えば、Terumo Corporationが開発した嚢内血流攪乱デバイスであるWoven EndoBridge（WEB）Aneurysm Embolization Systemは、2019年に米国FDAによって承認されました。

したがって、前述のすべての要因が、予測期間に神経血管塞栓デバイスの需要を強化すると見込まれます。

しかし、マイクロカテーテル、マイクロガイドワイヤー、コイルなどによる動脈瘤穿孔などの神経血管塞栓術に関連する特定の合併症が、市場を阻害する可能性が高いです。

前例のないCOVID-19パンデミックが神経血管塞栓デバイス市場を減速させています。これは、いくつかの国々でロックダウン、ソーシャルディスタンス規範、拡散防止措置が実施されたためです。さらに、手術の停止、くも膜下出血（SAH）の入院件数の減少、ウイルスの感染を防ぐための破裂動脈瘤のコイリング介入に加え、中でも、集中治療室（ICU）のほとんどがCOVID-19患者の大量流入で飽和したことから医療従事者の焦点がパンデミックの管理に移ったことも、市場に影響を与えました。

神経血管塞栓デバイス市場のセグメント分析

神経血管塞栓デバイス製品タイプセグメントでは、塞栓コイルが予測期間に大きな市場シェアを占めると予測されています。これは、塞栓コイルが広く入手可能であることや、先進の塞栓コイルを開発するメーカーによる取り組みの拡大によるものであり、患者集団におけるデバイスの採用率を高める可能性があります。例えば、2019年10月21日、Shape Memory Medicalは独自の形状記憶ポリマー（SMP）技術を特徴とするTrelliX® Embolic Coil SystemのCEマークを取得しました。

また、2019年9月17日、Wallaby Medicalは頭蓋内動脈瘤と動静脈奇形や動静脈瘻などのその他の神経血管異常の血管内塞栓術に使用することを想定し差別化された塞栓コイルシステムであるAvenir Coil SystemのCEマーク承認とFDA 510（k）認可を取得しました。本システムは、非常に安定したフレーミングコイル、大容量のフィリングコイル、非常に柔軟なフィニッシングコイルなど、あらゆる種類のコイルを提供します。

当レポートでは、世界の神経血管塞栓デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 神経血管塞栓デバイス市場レポートのイントロダクション

第2章 神経血管塞栓デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 神経血管塞栓デバイス市場の主な要因の分析

  • 神経血管塞栓デバイス市場の促進要因
    • 重度の頭部外傷、座りがちなライフスタイルなどによる脳動脈瘤、出血などの神経血管障害の有病率の増加
    • 世界中での高血圧の有病率の増加
    • 世界中での製品の承認と発売の増加
    • 老年人口の負担の増大
  • 神経血管塞栓デバイス市場の抑制要因と課題
    • 塞栓コイルに関連する合併症
    • 厳格な規制当局の承認
  • 神経血管塞栓デバイス市場の機会
    • 低中所得地域における成長機会
    • 主要企業間の戦略的パートナーシップによる成長機会

第5章 神経血管塞栓デバイスのポーターのファイブフォース分析

第6章 神経血管塞栓デバイス市場に対するCOVID-19の影響分析

第7章 神経血管塞栓デバイスの市場レイアウト

  • 製品タイプ別
    • 塞栓コイル
    • 神経血管コイル補助デバイス
    • 液体塞栓システム
    • 血流改変ステント
    • 嚢状内血流遮断装置
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 神経血管塞栓デバイス：世界の企業シェア分析 - 主要3～5社

第9章 神経血管塞栓デバイスの企業と製品のプロファイル

  • Medtronic
  • Stryker
  • MicroVention, Inc. (Terumo Corporation)
  • Johnson & Johnson Services, Inc.
  • Penumbra, Inc.
  • Balt
  • B. Braun Melsungen AG
  • Acandis GmbH
  • Wallaby Medical
  • Shape Memory Medical Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Spartan Micro, Inc.
  • KANEKA CORPORATION
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Boston Scientific Corporation
  • phenox GmbH
  • Merit Medical Systems
  • Perflow Medical Ltd
  • MicroPort Scientific Corporation.
  • Cerus Endovascular
  • Rapid Medical

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Table 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Table 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Table 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Table 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Table 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Table 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Table 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Table 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Table 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Table 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Table 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Table 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Table 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Table 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Table 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Table 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Table 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Table 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Table 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Table 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Table 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Table 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Table 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Table 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Table 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Table 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Table 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Figure 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Figure 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Figure 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Figure 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Figure 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Figure 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Figure 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Figure 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Figure 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Figure 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Figure 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Figure 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Figure 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Figure 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Figure 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Figure 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Figure 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Figure 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Figure 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Figure 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Figure 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Figure 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Figure 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Figure 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)
  • Figure 42 Market Drivers
  • Figure 43 Market Barriers
  • Figure 44 Market Opportunities
  • Figure 45 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0477

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents And Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), by geography, is expected to expand at a static CAGR forecast till 2030 due to the rising cases of hemorrhages and brain aneurysm in the population across the globe and launch of embolization products in different regions worldwide

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030. The rise in the demand for neurovascular embolization devices is predominantly attributed to the increasing prevalence of hemorrhages and the abnormalities in blood vessels present in the brain, increasing brain aneurysms and arteriovenous malformations (AVMs) due to sedentary lifestyles. Moreover, the rise in the geriatric population, increasing prevalence of high blood pressure, the launch of various embolization products, among others are the factors responsible for the global neurovascular embolization devices market growth.

Neurovascular Embolization Devices Market Dynamics:

The market for neurovascular embolization devices is gaining momentum at present owing to the rise in prevalence of hemorrhages and brain aneurysms among the population. According to the National Health Service (NHS), a publicly funded healthcare system, there are a lot of factors such as smoking, severe head injury, cocaine abuse, increase in blood pressure, among others that increases the risk of developing brain aneurysm among the population, thus would lead to an increase in the demand for neurovascular embolization devices. For instance, according to the data published by the World Health Organization (WHO) in the year 2023, approximately 1.28 billion adults aged between 30-79 years have hypertension across the globe. Also, the data mentioned that two-third of the population suffering from hypertension are living in low- and middle-income countries.

Furthermore, the ongoing expansion of the geriatric population would also contribute to the neurovascular embolization devices market in the forthcoming years. This is because brain aneurysm is common in adults between the ages of 30 and 60 and are more common in women than in men. According to the World Population Ageing 2020 Highlights published by the Population Division of the United Nations Department of Economic and Social Affairs (UN DESA), there were an estimated 727 million persons aged 65 years and above across the globe in the year 2020. As per the same report, women comprised of a majority of the older person, especially at an advanced age, and accounted for 55% of the global population aged 65 years and over in the year 2020.

In addition, approval of embolization products would also contribute to market growth. For instance, Woven EndoBridge (WEB) Aneurysm Embolization System, an Intrasaccular Flow Disruption Device developed by Terumo Corporation was approved by the US FDA in the year 2019.

Hence, all the aforementioned factors are anticipated to bolster the demand for neurovascular embolization devices during the forecasted period.

However, certain complications associated with the neurovascular embolization procedures such as procedural aneurysmal perforations by the microcatheter, micro-guidewire, or coil, among others are likely to impede the market.

The unprecedented COVID-19 pandemic has slowed down the market for neurovascular embolization devices. This is owing to the implementation of lockdown, the social distancing norms, and containment measures in several countries. Moreover, halt in surgeries, decreased volumes in subarachnoid hemorrhage (SAH) hospitalizations, and ruptured aneurysm coiling interventions to prevent the transmission of the virus, shifting focus of healthcare professionals to manage the pandemic as most of the intensive care units (ICU) were saturated with the massive influx of COVID-19 patients, among others also affected the market.

Neurovascular Embolization Devices Market Segment Analysis:

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents and Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Neurovascular Embolization Devices product type segment, the embolization coil is anticipated to hold a significant market share during the forecasted period. This is due to the wide availability of embolization coils and growing initiatives by the manufacturers to develop advanced embolization coils which in turn would increase the adoption rate of the devices among the patient population. For instance, on October 21, 2019, Shape Memory Medical received CE Mark for the TrelliX® Embolic Coil System which features proprietary shape memory polymer (SMP) technology.

Also, on September 17, 2019, Wallaby Medical received CE Mark approval and FDA 510(k) clearance for its differentiated embolic coil system, the Avenir Coil System intended to use for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The system offers a full line of coils including exceptional stable framing coils, extra volume filling coils, and ultra-soft finishing coils.

In addition, companies raising funds for the development and commercialization of neurovascular embolic coils are also expected to contribute to the segmental growth of the neurovascular embolization devices market. For instance, in July 2022, Zylox-Tonbridge Medical Technology Co., Ltd., a neuro- and peripheral-vascular interventional medical device company raised USD 329 million to support the development and commercialization of its core products which include neurovascular embolization coils, a micro catheter for coiling, among others.

Thus, all the above-mentioned factors would boost the market for neurovascular embolization devices in the upcoming years.

North America is expected to dominate the overall Neurovascular Embolization Devices Market:

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

For instance, as per the 2022 data of the Brain Aneurysm Foundation, an estimated 6.5 million people in the US have an unruptured brain aneurysm in the year 2020 and about 30,000 people suffer from a brain aneurysm rupture each year.

In addition, an increase in government initiatives and funding to support research for brain aneurysms in the country would also increase the regional market for neurovascular embolization devices. For instance, as per the bill presented in the 117 session on March 03, 2022, USD 10,000,000 has been funded by the government to conduct or support further comprehensive research on unruptured intracranial aneurysms for each of fiscal years 2022 through 2028 which will remain available through September 30, 2029.

Moreover, strategic business activities and approval of products in the region would also boost the regional market for neurovascular embolization devices. For instance, in the year 2020, Kaneka Corporation received FDA approval for its new brain aneurysm Embolization coil, i-ED COIL(TM).

Hence, the interplay of all the aforementioned factors will bolster the demand for the neurovascular embolization market in the region during the forecasted period.

Furthermore, the Asia-pacific region has future potential for the neurovascular embolization devices market. This is owing to the rising sedentary lifestyle such as consumption of alcohol, increase in aging population, growing head injuries, among others. For instance, as per the World Bank Group 2022 data, in the year 2020, China had 168,863,853 population aged 65 and above.

In addition, strategic business activity to expand the domestic market in the APAC region would also contribute to the neurovascular embolization devices market. For instance, in the year 2020, Genesis MedTech Group acquired Minitech Medical, a leading domestic enterprise in the neurovascular industry, and successfully developed and launched its first domestically-made intracranial embolization stent. Hence, all of these factors are likely to make APAC the fastest market for neurovascular embolization devices during the forecasted period.

Neurovascular Embolization Devices Market Key Players:

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

Recent Developmental Activities in the Neurovascular Embolization Devices Market:

In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. ("MicroPort® NeuroTech") received the registration certificates issued by China's National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.

In April 2020, Cerus Endovascular received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device designed for the treatment of intracranial aneurysms.

In May 2019, Rapid Medical, a company focused on the development of next-generation neurovascular devices, received FDA clearance for the Comaneci device as a temporary coil embolization assist device.

Key Takeaways from the Neurovascular Embolization Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurovascular Embolization Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Neurovascular Embolization Devices Market.

Various opportunities available for the other competitor in the Neurovascular Embolization Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Neurovascular Embolization Devices market growth in the coming future?

Target Audience who can be benefited from the Neurovascular Embolization Devices Market Report Study

Neurovascular Embolization Devices providers

Research organizations and consulting companies

Neurovascular Embolization Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Neurovascular Embolization Devices

Various End-users who want to know more about the Neurovascular Embolization Devices Market and latest technological developments in the Neurovascular Embolization Devices market.

Frequently Asked Questions for the Neurovascular Embolization Devices Market:

1. What are Neurovascular Embolization Devices?

A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral arteriovenous malformations.

2. What is the market for Global Neurovascular Embolization Devices?

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030.

3. What are the drivers for the Global Neurovascular Embolization Devices?

The major factors driving the demand for Neurovascular Embolization Devices are the rising cases of hemorrhage stroke, brain aneurysm, and cerebral arteriovenous malformations due to sedentary lifestyles such as excessive consumption of alcohol, serious head injuries, and others. In addition, the rising prevalence of high blood pressure, growing product approval, and increase in the aging population, among others are also expected to boost the market.

4. What are the key players operating in Global Neurovascular Embolization Devices?

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

5. Which region has the highest share in the Neurovascular Embolization Devices market?

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

Table of Contents

1.Neurovascular Embolization Devices Market Report Introduction

2.Neurovascular Embolization Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Neurovascular Embolization Devices Market Key factors analysis

  • 4.1 Neurovascular Embolization Devices Market Drivers
    • 4.1.1 Growing prevalence of neurovascular disorders such as brain aneurysm, hemorrhage, and others due to severe head injuries, sedentary lifestyle, others
    • 4.1.2 Increase in prevalence of hypertension across the globe
    • 4.1.3 Increasing product approval & launches across the globe
    • 4.1.4 The growing burden of the geriatric population
  • 4.2 Neurovascular Embolization Devices Market Restraints and Challenges
    • 4.2.1 Complications associated with embolization coils
    • 4.2.2 Stringent regulatory approvals
  • 4.3 Neurovascular Embolization Devices Market Opportunities
    • 4.3.1 Growth opportunities in low and middle-income regions
    • 4.3.2 Growth opportunities due to strategic partnership among key players

5. Neurovascular Embolization Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Neurovascular Embolization Devices Market

7. Neurovascular Embolization Devices Market layout

  • 7.1 By Product Type
    • 7.1.1 Embolization Coils
    • 7.1.2 Neurovascular Coil Assist Devices
      • 7.1.2.1 Coil Assist Stents
      • 7.1.2.2 Coil Assist Balloons
    • 7.1.3 Liquid Embolization Systems
    • 7.1.4 Flow diversion stents
    • 7.1.5 Intrasaccular flow disruptor
    • 7.1.6 Others
  • 7.2 By End-user
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 North America Neurovascular Embolization Devices Market, by Product Type
      • 7.3.1.2 North America Neurovascular Embolization Devices Market, by End User
      • 7.3.1.3 North America Neurovascular Embolization Devices Market, by Country
      • 7.3.1.3.1 United States
      • 7.3.1.3.2 Canada
      • 7.3.1.3.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 Europe Neurovascular Embolization Devices Market, by Product Type
      • 7.3.2.2 Europe Neurovascular Embolization Devices Market, by End User
      • 7.3.2.3 Europe Neurovascular Embolization Devices Market, by Country
      • 7.3.2.3.1 France
      • 7.3.2.3.2 Germany
      • 7.3.2.3.3 United Kingdom
      • 7.3.2.3.4 Italy
      • 7.3.2.3.5 Spain
      • 7.3.2.3.6 Russia
      • 7.3.2.3.7 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 Asia-Pacific Neurovascular Embolization Devices Market, by Product Type
      • 7.3.3.2 Asia-Pacific Neurovascular Embolization Devices Market, by End User
      • 7.3.3.3 Asia-Pacific Neurovascular Embolization Devices Market, by Country
      • 7.3.3.3.1 China
      • 7.3.3.3.2 Japan
      • 7.3.3.3.3 India
      • 7.3.3.3.4 Australia
      • 7.3.3.3.5 South Korea
      • 7.3.3.3.6 Rest of Asia Pacific
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 RoW Neurovascular Embolization Devices Market, by Product Type
      • 7.3.4.2 RoW Neurovascular Embolization Devices Market, by End User
      • 7.3.4.3 RoW Neurovascular Embolization Devices Market, by Region
      • 7.3.4.3.1 Middle East
      • 7.3.4.3.2 Africa
      • 7.3.4.3.3 South America

8. Neurovascular Embolization Devices Global Company Share Analysis - Key 3-5 Companies

9. Neurovascular Embolization Devices Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Stryker
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 MicroVention, Inc. (Terumo Corporation)
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Johnson & Johnson Services, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Penumbra, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Balt
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 B. Braun Melsungen AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Acandis GmbH
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Wallaby Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Shape Memory Medical Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Zylox-Tonbridge Medical Technology Co., Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Spartan Micro, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 KANEKA CORPORATION
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Lepu Medical Technology (Beijing) Co., Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Boston Scientific Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 phenox GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Merit Medical Systems
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Perflow Medical Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 MicroPort Scientific Corporation.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy
  • 9.21 Cerus Endovascular
    • 9.21.1. Company Overview
    • 9.21.2. Company Snapshot
    • 9.21.3. Financial Overview
    • 9.21.4 Product Listing
    • 9.21.5. Entropy
  • 9.22 Rapid Medical
    • 9.22.1. Company Overview
    • 9.22.2. Company Snapshot
    • 9.22.3. Financial Overview
    • 9.22.4 Product Listing
    • 9.22.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us